Skip to content

Playal 20

by Innate s.r.l. EUDAMED

Active European Union

Ref INN139, INN54Model Playal 80, 2 mL syringe based on high molecular weight sodium hyaluronate and niacinamide

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number063-00-01-MDR Date7 Sep 2026IssuedStatusActive expires 13 Nov 2029

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Certificates

2 certificates · EUDAMED

EUDAMED certificates (2)
  • 063-00-01-MDR Active Supplemented

    Quality management system EU MDR

    Notified body
    ITALCERT SRL 0426
    Issued
    7 Sep 2026
    Expires
    13 Nov 2029
    Reason
    Other
  • 064-00-02-MDR Active Supplemented

    Technical documentation EU MDR

    Notified body
    ITALCERT SRL 0426
    Issued
    7 Sep 2026
    Expires
    13 Nov 2029
    Reason
    Other

Specification

EUDAMED

Device Name
Playal Family
Model / Reference
Playal 80, INN139, 2 mL syringe based on high molecular weight sodium hyaluronate and niacinamide, INN54
Primary DI / UDI-DI
08051040331687, 08051040330543
Basic UDI-DI
805104033artsyrniaci77U, B-08051040330543
EMDN Code
P900402 Resorbable filling and reconstruction devices
Device Class
Class III
Market of Registration
Italy

Manufacturer details

EUDAMED SRN
IT-MF-000026730

Other devices from Innate s.r.l.

See all devices from Innate s.r.l. →

Properties

  • Sterile
  • Implantable

Other properties (11)

  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No